However, when compared to other actionable genotypes on ACMG [7] or CDC tier 1 [35] list, such as breast cancer related genotypes, HFE C282Y (+/+) can be considered a rather “benign” genotype with efficacious interventions. This evidence concerns the gene HFE and breast cancer.